THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
MEDICINE MONOGRAPH CODE: [10.3]-C102 ID: TIP-MED-000372

B3

Active Ingredient / Scientific Identity: B3 • Class: Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid & Neural Myelin Metabolism Cofactors)

⚖️ Compare Profile
Generic / Entity NameB3 ([10.3]-C102)
Verified Indian Brands / RefGeneric Compendial Entry (No Commercial Brand Claimed)
Pharmacological ClassWater-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid & Neural Myelin Metabolis
Available Dosage FormsOral Capsules / Film-Coated Tablets & Syrups (Typical Therapeutic Formula: Thiamine [B1] 10 mg, Riboflavin [B2
Regulatory ClassificationNon-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommend
Key Warning & Review DateRenal: Water-soluble; safe at 1 tablet/day in mild-to-moderate CKD (in dialysis patients, specialized renal B-complex [Nephro
Reviewed: 2026-11-10
Safety Matrix:⚖️ Legal Status: Non-Schedule / OTC or Schedule K Permitted Preparati✔️ Standard Clinical Dispensing Precautions

1. Clinical & Scientific Overview

B3 (TIP-MED-000372, Reference Code [10.3]-C102) is classified under Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid & Neural Myelin Metabolism Cofactors). Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).

Verified Indian Market Examples / Compendial Status:
Co-indexed constituent under primary monograph [10.3] (Vitamin B-Complex (Therapeutic B1, B2, B3, B5, B6, B7, B9, B12 Combinations)). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.3], p. 128): Becosules (Pfizer—B-Complex + Vitamin C + Biotin), Neurobion Forte (Procter & Gamble—High-Dose Neurotropic B1+B2+B3+B5+B6+B12), Cobadex-CZS (GSK), Polybion (Merck), Beplex Forte — Strengths & Dosage Forms: Oral Capsules / Film-Coated Tablets & Syrups (Typical Therapeutic Formula: Thiamine [B1] 10 mg, Riboflavin [B2] 10 mg, Niacinamide [B3] 45–100 mg, Calcium Pantothenate [B5] 50 mg, Pyridoxine [B6] 3–10 mg, Biotin [B7] 100 mcg, Folic Acid [B9] 1.5 mg, Cyanocobalamin/Methylcobalamin [B12] 15 mcg + Ascorbic Acid [Vit C] 150 mg)
Co-indexed constituent under primary monograph [10.3] (Vitamin B-Complex (Therapeutic B1, B2, B3, B5, B6, B7, B9, B12 Combinations)). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.3], p. 128): Becosules (Pfizer—B-Complex + Vitamin C + Biotin), Neurobion Forte (Procter & Gamble—High-Dose Neurotropic B1+B2+B3+B5+B6+B12), Cobadex-CZS (GSK), Polybion (Merck), Beplex Forte — Strengths & Dosage Forms: Oral Capsules / Film-Coated Tablets & Syrups (Typical Therapeutic Formula: Thiamine [B1] 10 mg, Riboflavin [B2] 10 mg, Niacinamide [B3] 45–100 mg, Calcium Pantothenate [B5] 50 mg, Pyridoxine [B6] 3–10 mg, Biotin [B7] 100 mcg, Folic Acid [B9] 1.5 mg, Cyanocobalamin/Methylcobalamin [B12] 15 mcg + Ascorbic Acid [Vit C] 150 mg)
Dosage Forms & Available Strengths:
Oral Capsules / Film-Coated Tablets & Syrups (Typical Therapeutic Formula: Thiamine [B1] 10 mg, Riboflavin [B2] 10 mg, Niacinamide [B3] 45–100 mg, Calcium Pantothenate [B5] 50 mg, Pyridoxine [B6] 3–10 mg, Biotin [B7] 100 mcg, Folic Acid [B9] 1.5 mg, Cyanocobalamin/Methylcobalamin [B12] 15 mcg + Ascorbic Acid [Vit C] 150 mg)
Routes: Oral / Parenteral / Topical per formulation

3. Mechanism of Action & Pharmacodynamics

Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid & Neural Myelin Metabolism Cofactors) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid & Neural Myelin Metabolism Cofactors) for Prophylaxis and treatment of water-soluble B-vitamin deficiencies during prolonged febrile illness, broad-spectrum antibiotic courses, restricted diets, malabsorption, chronic alcoholism (Wernicke-Korsakoff prophylaxis requires high-dose parenteral Thiamine B1 100–500 mg!), glossitis, cheilosis, angular stomatitis, and peripheral neuropathy (especially Isoniazid-induced B6 deficiency)..

4. Therapeutic Indications & Evidence-Supported Uses

  • Prophylaxis and treatment of water-soluble B-vitamin deficiencies during prolonged febrile illness, broad-spectrum antibiotic courses, restricted diets, malabsorption, chronic alcoholism (Wernicke-Korsakoff prophylaxis requires high-dose parenteral Thiamine B1 100–500 mg!), glossitis, cheilosis, angular stomatitis, and peripheral neuropathy (especially Isoniazid-induced B6 deficiency)

🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.

5. Educational Dosage Context, Formulations & Administration

Educational Dosing & Regimen Summary: General Adult Reference: 1 capsule or tablet once daily after a meal. Follow physician prescription.

Administration & Meal Timing: Take WITH or immediately AFTER breakfast or lunch (taking high-strength B-complex capsules on an empty stomach frequently causes a Vitamin-B odour burp and mild nausea). | Once daily in the morning or afternoon after food.

6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment

Absorption & Disposition:
Follows class pharmacokinetic profile detailed in parent monograph [10.3].
Metabolism & Biotransformation:
Renal: Water-soluble; safe at 1 tablet/day in mild-to-moderate CKD (in dialysis patients, specialized renal B-complex [Nephrocaps] without fat-soluble Vit A is used to replace dialysed water-soluble vitamins). Hepatic: Essential in alcoholic liver disease.
Elimination & Renal Adjustment:
Renal: Water-soluble; safe at 1 tablet/day in mild-to-moderate CKD (in dialysis patients, specialized renal B-complex [Nephrocaps] without fat-soluble Vit A is used to replace dialysed water-soluble vitamins). Hepatic: Essential in alcoholic liver disease.
Hepatic Impairment Considerations:
Renal: Water-soluble; safe at 1 tablet/day in mild-to-moderate CKD (in dialysis patients, specialized renal B-complex [Nephrocaps] without fat-soluble Vit A is used to replace dialysed water-soluble vitamins). Hepatic: Essential in alcoholic liver disease.

7. Contraindications, Precautions & High-Risk Warnings

Contraindications & Red-Flag Precautions:
  • Avoid megadose Pyridoxine (Vitamin B6 >100–200 mg/day for months), which paradoxically causes sensory peripheral neuropathy and dorsal root ganglion toxicity! High-dose Biotin (Vitamin B7 ≥5–10 mg/day) interferes with streptavidin-biotin laboratory immunoassays.

Key Clinical Precautions: Renal: Water-soluble; safe at 1 tablet/day in mild-to-moderate CKD (in dialysis patients, specialized renal B-complex [Nephrocaps] without fat-soluble Vit A is used to replace dialysed water-soluble vitamins). Hepatic: Essential in alcoholic liver disease.

8. Adverse Effects Profile

Common & Mechanism-Related Adverse Effects:
  • Bright fluorescent neon-yellow discolouration of urine (caused by harmless renal excretion of unabsorbed Riboflavin [Vitamin B2]!), mild vitamin aftertaste/eructation, rare GI discomfort.
  • Sensory ataxia and peripheral neuropathy (only with chronic excessive Vitamin B6 megadoses >100–200 mg/day), false laboratory immunoassay results (from high Biotin).
Serious / Dose-Limiting Adverse Effects:

    9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions

    • Levodopa Alone: Pyridoxine (Vitamin B6 >5–10 mg) accelerates peripheral decarboxylation of Levodopa, reducing brain delivery—however, this interaction does NOT occur when Levodopa is combined with Carbidopa or Benserazide (Syndopa / Madopar), as standard in modern Parkinson's therapy! 2
    • Phenytoin & Phenobarbitone: High-dose Folic Acid and Pyridoxine inside B-complex capsules can accelerate hepatic metabolism of phenytoin, lowering serum phenytoin levels
    • Biotin Laboratory Interference: Biotin interferes with Thyroid (TSH, Free T4/T3—mimicking Graves' hyperthyroidism!) and Cardiac Troponin blood tests—stop B-complex containing high biotin 48 hours before thyroid blood draws!

    10. Clinical Monitoring, Patient Counselling & Storage

    Clinical & Laboratory Monitoring: Monitor clinical parameters per parent monograph [10.3].

    Pharmacist Patient Counselling Points:

    • Patient Counselling Checklist: Reassure every patient starting Becosules or Neurobion Forte that bright fluorescent yellow urine within 2 hours of taking the capsule is completely normal and harmless (it is simply excess Vitamin B2 leaving the body—do not stop the capsule thinking it is jaundice or kidney heat!). Remind thyroid patients to pause biotin-containing vitamins for 2 days before a TSH blood test.
    • Meal & Clock Timing Instruction: Take WITH or immediately AFTER breakfast or lunch (taking high-strength B-complex capsules on an empty stomach frequently causes a Vitamin-B odour burp and mild nausea). (Once daily in the morning or afternoon after food.)
    • Missed Dose Protocol: Take with the next meal on the same day; skip if remembered the next day.
    • Geriatric Dispensing Pearl: Check that elderly neuropathy patients are not taking 2 or 3 different B-complex/B6 preparations simultaneously, as cumulative Pyridoxine (B6) >50–100 mg/day can worsen nerve numbness.

    Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Capsules / Film-Coated Tablets & Syrups (Typical Therapeutic Formula: Thiamine [B1] 10 mg, Riboflavin [B2] 10 mg, Niacinamide [B3] 45–100 mg, Calcium Pantothenate [B5] 50 mg, Pyridoxine [B6] 3–10 mg, Biotin [B7] 100 mcg, Folic Acid [B9] 1.5 mg, Cyanocobalamin/Methylcobalamin [B12] 15 mcg + Ascorbic Acid [Vit C] 150 mg)

    11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)

    THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
    svg-v339-01-adme-12-step-journey — 8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

    12. Authoritative References, Regulatory Sources & Editorial Disclaimer

    Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO

    Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)

    Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT

    Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.